159 related articles for article (PubMed ID: 24796332)
21. Suppression of cathepsin a inhibits growth, migration, and invasion by inhibiting the p38 MAPK signaling pathway in prostate cancer.
Park S; Kwon W; Park JK; Baek SM; Lee SW; Cho GJ; Ha YS; Lee JN; Kwon TG; Kim MO; Ryoo ZY; Han SH; Han JE; Choi SK
Arch Biochem Biophys; 2020 Jul; 688():108407. PubMed ID: 32407712
[TBL] [Abstract][Full Text] [Related]
22. ERK5 signalling in prostate cancer promotes an invasive phenotype.
Ramsay AK; McCracken SR; Soofi M; Fleming J; Yu AX; Ahmad I; Morland R; Machesky L; Nixon C; Edwards DR; Nuttall RK; Seywright M; Marquez R; Keller E; Leung HY
Br J Cancer; 2011 Feb; 104(4):664-72. PubMed ID: 21266977
[TBL] [Abstract][Full Text] [Related]
23. IFITM3 promotes bone metastasis of prostate cancer cells by mediating activation of the TGF-β signaling pathway.
Liu X; Chen L; Fan Y; Hong Y; Yang X; Li Y; Lu J; Lv J; Pan X; Qu F; Cui X; Gao Y; Xu D
Cell Death Dis; 2019 Jul; 10(7):517. PubMed ID: 31273201
[TBL] [Abstract][Full Text] [Related]
24. RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo.
Pulukuri SM; Gondi CS; Lakka SS; Jutla A; Estes N; Gujrati M; Rao JS
J Biol Chem; 2005 Oct; 280(43):36529-40. PubMed ID: 16127174
[TBL] [Abstract][Full Text] [Related]
25. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
Tyagi A; Agarwal R; Agarwal C
Oncogene; 2003 Mar; 22(9):1302-16. PubMed ID: 12618755
[TBL] [Abstract][Full Text] [Related]
26. NADPH oxidase subunit p22(phox)-mediated reactive oxygen species contribute to angiogenesis and tumor growth through AKT and ERK1/2 signaling pathways in prostate cancer.
Li Q; Fu GB; Zheng JT; He J; Niu XB; Chen QD; Yin Y; Qian X; Xu Q; Wang M; Sun AF; Shu Y; Rui H; Liu LZ; Jiang BH
Biochim Biophys Acta; 2013 Dec; 1833(12):3375-3385. PubMed ID: 24113386
[TBL] [Abstract][Full Text] [Related]
27. Novel role of Giα2 in cell migration: Downstream of PI3-kinase-AKT and Rac1 in prostate cancer cells.
Caggia S; Chunduri H; Millena AC; Perkins JN; Venugopal SV; Vo BT; Li C; Tu Y; Khan SA
J Cell Physiol; 2018 Jan; 234(1):802-815. PubMed ID: 30078221
[TBL] [Abstract][Full Text] [Related]
28. S100A16 promotes cell proliferation and metastasis via AKT and ERK cell signaling pathways in human prostate cancer.
Zhu W; Xue Y; Liang C; Zhang R; Zhang Z; Li H; Su D; Liang X; Zhang Y; Huang Q; Liu M; Li L; Li D; Zhao AZ; Liu Y
Tumour Biol; 2016 Sep; 37(9):12241-12250. PubMed ID: 27240591
[TBL] [Abstract][Full Text] [Related]
29. Nitric Oxide Up-Regulates RUNX2 in LNCaP Prostate Tumours: Implications for Tumour Growth In Vitro and In Vivo.
Nesbitt H; Browne G; O'Donovan KM; Byrne NM; Worthington J; McKeown SR; McKenna DJ
J Cell Physiol; 2016 Feb; 231(2):473-82. PubMed ID: 26189652
[TBL] [Abstract][Full Text] [Related]
30. HOXA1 enhances the cell proliferation, invasion and metastasis of prostate cancer cells.
Wang H; Liu G; Shen D; Ye H; Huang J; Jiao L; Sun Y
Oncol Rep; 2015 Sep; 34(3):1203-10. PubMed ID: 26135141
[TBL] [Abstract][Full Text] [Related]
31. STAMP1 is both a proliferative and an antiapoptotic factor in prostate cancer.
Wang L; Jin Y; Arnoldussen YJ; Jonson I; Qu S; Maelandsmo GM; Kristian A; Risberg B; Waehre H; Danielsen HE; Saatcioglu F
Cancer Res; 2010 Jul; 70(14):5818-28. PubMed ID: 20587517
[TBL] [Abstract][Full Text] [Related]
32. Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation.
Sen A; De Castro I; Defranco DB; Deng FM; Melamed J; Kapur P; Raj GV; Rossi R; Hammes SR
J Clin Invest; 2012 Jul; 122(7):2469-81. PubMed ID: 22684108
[TBL] [Abstract][Full Text] [Related]
33. Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.
Chang TP; Yu SL; Lin SY; Hsiao YJ; Chang GC; Yang PC; Chen JJ
Cancer Res; 2010 Feb; 70(4):1656-67. PubMed ID: 20145123
[TBL] [Abstract][Full Text] [Related]
34. miR-105 inhibits prostate tumour growth by suppressing CDK6 levels.
Honeywell DR; Cabrita MA; Zhao H; Dimitroulakos J; Addison CL
PLoS One; 2013; 8(8):e70515. PubMed ID: 23950948
[TBL] [Abstract][Full Text] [Related]
35. Effects of transferred NK4 gene on proliferation, migration, invasion and apoptosis of human prostate cancer DU145 cells.
Yue D; Wang Y; Ma P; Li YY; Chen H; Wang P; Ren CS
Asian J Androl; 2010 May; 12(3):381-9. PubMed ID: 20400971
[TBL] [Abstract][Full Text] [Related]
36. Combined targeting of epidermal growth factor receptor and MDM2 by gefitinib and antisense MDM2 cooperatively inhibit hormone-independent prostate cancer.
Bianco R; Caputo R; Caputo R; Damiano V; De Placido S; Ficorella C; Agrawal S; Bianco AR; Ciardiello F; Tortora G
Clin Cancer Res; 2004 Jul; 10(14):4858-64. PubMed ID: 15269162
[TBL] [Abstract][Full Text] [Related]
37. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z
PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772
[TBL] [Abstract][Full Text] [Related]
38. Epidermal growth factor modulates prostate cancer cell invasiveness regulating urokinase-type plasminogen activator activity. EGF-receptor inhibition may prevent tumor cell dissemination.
Festuccia C; Angelucci A; Gravina GL; Biordi L; Millimaggi D; Muzi P; Vicentini C; Bologna M
Thromb Haemost; 2005 May; 93(5):964-75. PubMed ID: 15886816
[TBL] [Abstract][Full Text] [Related]
39. ARF1 promotes prostate tumorigenesis via targeting oncogenic MAPK signaling.
Davis JE; Xie X; Guo J; Huang W; Chu WM; Huang S; Teng Y; Wu G
Oncotarget; 2016 Jun; 7(26):39834-39845. PubMed ID: 27213581
[TBL] [Abstract][Full Text] [Related]
40. Vasoactive intestinal peptide transactivates the androgen receptor through a protein kinase A-dependent extracellular signal-regulated kinase pathway in prostate cancer LNCaP cells.
Xie Y; Wolff DW; Lin MF; Tu Y
Mol Pharmacol; 2007 Jul; 72(1):73-85. PubMed ID: 17430995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
